• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research.患者中心结局研究中治疗效果异质性分析框架。
J Clin Epidemiol. 2013 Aug;66(8):818-25. doi: 10.1016/j.jclinepi.2013.02.009. Epub 2013 May 4.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.随机对照试验中的亚组分析:量化假阳性和假阴性风险
Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330.
4
5
6
From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer.从治疗效果异质性的概念、理论和证据到方法学方法:简介。
BMC Med Res Methodol. 2012 Dec 13;12:185. doi: 10.1186/1471-2288-12-185.
7
Prospective meta-analysis using individual patient data in intensive care medicine.前瞻性荟萃分析,使用重症监护医学中的个体患者数据。
Intensive Care Med. 2010 Jan;36(1):11-21. doi: 10.1007/s00134-009-1650-x. Epub 2009 Sep 18.
8
9
10
Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.高效两步法多元随机效应个体参与者数据纵向临床试验混合效应模型荟萃分析。
BMC Med Res Methodol. 2019 Feb 14;19(1):33. doi: 10.1186/s12874-019-0676-1.

引用本文的文献

1
Primed for Precision: A Review of the Evidence for Heterogeneous Treatment Effects in Diabetes Distress Treatments Among Adults with Type 1 Diabetes and Recommendations for Future Research.精准准备:1型糖尿病成人患者糖尿病困扰治疗中异质性治疗效果的证据综述及未来研究建议
Curr Diab Rep. 2025 Jun 18;25(1):37. doi: 10.1007/s11892-025-01594-2.
2
Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV.针对生存时间结局的治疗效果异质性的精准医学评估及其在HIV感染者初始治疗试验中的应用
Clin Trials. 2025 May 22:17407745251338558. doi: 10.1177/17407745251338558.
3
Did a digital quality of life (QOL) assessment and practice support system in home health care improve the QOL of older adults living with life-limiting conditions and of their family caregivers? A mixed-methods pragmatic randomized controlled trial.家庭医疗保健中的数字生活质量(QOL)评估与实践支持系统是否改善了患有生命受限疾病的老年人及其家庭护理人员的生活质量?一项混合方法实用随机对照试验。
PLoS One. 2025 May 6;20(5):e0320306. doi: 10.1371/journal.pone.0320306. eCollection 2025.
4
Characterizing Treatment Effect Heterogeneity Using Real-World Data.使用真实世界数据表征治疗效果异质性
Clin Pharmacol Ther. 2025 May;117(5):1209-1216. doi: 10.1002/cpt.3627. Epub 2025 Mar 6.
5
A minimum dataset for destination therapy with left ventricular assist device: the evidence that matters to decision makers.左心室辅助装置目标治疗的最小数据集:对决策者至关重要的证据。
Int J Technol Assess Health Care. 2025 Jan 17;41(1):e8. doi: 10.1017/S0266462325000054.
6
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies.迈向重症监护研究的精准化:观察性和干预性研究方法。
Crit Care Med. 2024 Sep 1;52(9):1439-1450. doi: 10.1097/CCM.0000000000006371. Epub 2024 Aug 15.
7
Comparative effectiveness of an individualized model of hemodialysis vs conventional hemodialysis: a study protocol for a multicenter randomized controlled trial (the TwoPlus trial).个体化血液透析模型与常规血液透析的比较效果:一项多中心随机对照试验(TwoPlus 试验)的研究方案。
Trials. 2024 Jun 28;25(1):424. doi: 10.1186/s13063-024-08281-9.
8
Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia.SarQoL 问卷的内容效度,一种针对肌肉减少症的生活质量问卷。
Aging Clin Exp Res. 2024 Apr 30;36(1):101. doi: 10.1007/s40520-024-02756-0.
9
Analysis of core outcome set reporting in coronary intervention trials.冠状动脉介入治疗试验核心结局指标报告分析。
Open Heart. 2024 Apr 30;11(1):e002581. doi: 10.1136/openhrt-2023-002581.
10
Leveraging Single-Case Experimental Designs to Promote Personalized Psychological Treatment: Step-by-Step Implementation Protocol with Stakeholder Involvement of an Outpatient Clinic for Personalized Psychotherapy.利用单病例实验设计促进个性化心理治疗:涉及个性化心理治疗门诊利益相关者的一步一步实施协议。
Adm Policy Ment Health. 2024 Sep;51(5):702-724. doi: 10.1007/s10488-024-01363-5. Epub 2024 Mar 11.

本文引用的文献

1
Meta-analysis of statin effects in women versus men.他汀类药物对女性与男性影响的荟萃分析。
J Am Coll Cardiol. 2012 Feb 7;59(6):572-82. doi: 10.1016/j.jacc.2011.09.067.
2
The Patient-Centered Outcomes Research Institute--promoting better information, decisions, and health.以患者为中心的结果研究机构——促进更优质的信息、决策和健康。
N Engl J Med. 2011 Oct 13;365(15):e31. doi: 10.1056/NEJMp1109407.
3
Sensitivity analysis for interactions under unmeasured confounding.在存在未测量混杂因素的情况下进行交互作用的敏感性分析。
Stat Med. 2012 Sep 28;31(22):2552-64. doi: 10.1002/sim.4354. Epub 2011 Oct 4.
4
Estimating treatment effects for individual patients based on the results of randomised clinical trials.根据随机临床试验的结果估算个体患者的治疗效果。
BMJ. 2011 Oct 3;343:d5888. doi: 10.1136/bmj.d5888.
5
Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials.审视证据:一项关于纳入和分析老年人群体的随机对照试验的系统评价。
J Gen Intern Med. 2011 Jul;26(7):783-90. doi: 10.1007/s11606-010-1629-x. Epub 2011 Feb 1.
6
Analysis of randomized comparative clinical trial data for personalized treatment selections.个性化治疗选择的随机对照临床试验数据分析。
Biostatistics. 2011 Apr;12(2):270-82. doi: 10.1093/biostatistics/kxq060. Epub 2010 Sep 28.
7
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.评估和报告临床试验中治疗效果的异质性:建议。
Trials. 2010 Aug 12;11:85. doi: 10.1186/1745-6215-11-85.
8
Comparative effectiveness research: challenges for medical journals.比较效果研究:医学期刊面临的挑战
Am J Manag Care. 2010 May 1;16(5):e131-3.
9
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.亚组效应可信吗?更新评估亚组分析可信度的标准。
BMJ. 2010 Mar 30;340:c117. doi: 10.1136/bmj.c117.
10
Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?评估治疗效果的异质性:作者是否误解了他们的结果?
Health Serv Res. 2010 Feb;45(1):283-301. doi: 10.1111/j.1475-6773.2009.01064.x.

患者中心结局研究中治疗效果异质性分析框架。

A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research.

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

J Clin Epidemiol. 2013 Aug;66(8):818-25. doi: 10.1016/j.jclinepi.2013.02.009. Epub 2013 May 4.

DOI:10.1016/j.jclinepi.2013.02.009
PMID:23651763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4450361/
Abstract

Individuals vary in their response to a treatment. Understanding this heterogeneity of treatment effect is critical for evaluating how well a treatment can be expected to work for an individual or a subgroup of individuals. An overemphasis on hypothesis testing has resulted in a dichotomy of all heterogeneity of treatment effect analyses into confirmatory (hypothesis testing) and exploratory (hypothesis finding) analyses. This limited view of heterogeneity of treatment effect is inadequate for creating evidence that is useful for informing patient-centered decisions. An expanded framework for heterogeneity of treatment effect assessment is proposed. It recognizes four distinct goals of heterogeneity of treatment effect analyses: hypothesis testing, hypothesis finding, reporting subgroup effects for meta-analysis, and individual-level prediction. Accordingly, two new types of heterogeneity of treatment effect analyses are proposed: descriptive and predictive. Descriptive heterogeneity of treatment effect analyses report treatment effects for prespecified subgroups in accordance with prospectively specified analytic strategy. They need not be powered to detect heterogeneity of treatment effect. They emphasize estimation and reporting of subgroup effects rather than hypothesis testing. Sampling properties (e.g., standard error) of descriptive analysis can be characterized, thus facilitating meta-analysis of subgroup effects. Predictive heterogeneity of treatment effect analyses estimate probabilities of beneficial and adverse responses of individuals to treatments and facilitates optimal treatment decisions for different types of individuals. Procedures are also suggested to improve reliability of heterogeneity of treatment effect assessment from observational studies. Heterogeneity of treatment effect analysis should be identified as confirmatory, descriptive, exploratory, or predictive analysis. Evidence should be interpreted in a manner consistent with the analytic goal.

摘要

个体对治疗的反应存在差异。了解这种治疗效果的异质性对于评估治疗对个体或亚组的效果如何至关重要。过度强调假设检验导致所有治疗效果异质性分析分为确证性(假设检验)和探索性(假设发现)分析。这种对治疗效果异质性的有限看法不足以提供有用的证据,以支持以患者为中心的决策。本文提出了一种扩展的治疗效果异质性评估框架。它认识到治疗效果异质性分析的四个不同目标:假设检验、假设发现、为荟萃分析报告亚组效应和个体水平预测。因此,提出了两种新的治疗效果异质性分析类型:描述性和预测性。描述性治疗效果异质性分析按照前瞻性指定的分析策略报告预先指定亚组的治疗效果。它们不需要有检测治疗效果异质性的功效。它们强调亚组效应的估计和报告,而不是假设检验。可以描述描述性分析的抽样特性(例如标准误差),从而促进亚组效应的荟萃分析。预测性治疗效果异质性分析估计个体对治疗的有益和不良反应的概率,并促进不同类型个体的最佳治疗决策。还提出了一些程序来提高来自观察性研究的治疗效果异质性评估的可靠性。治疗效果异质性分析应被确定为确证性、描述性、探索性或预测性分析。应根据分析目标的一致性来解释证据。